Overview

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

Status:
Active, not recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

This phase III trial is studying how well the combination of chemoradiation or radiation works in resected locally advanced cancer of the esophagus or gastroesophageal junction.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Zefen Xiao

Treatments:

Cisplatin
Nedaplatin
Paclitaxel